Allergan Plc (NYSE:AGN)’s share price plunged -3.31% or -4.54 to reach at $132.44 during previous trading session. A total of 2.99 Million shares exchanged hands, whereas the company’s average trading volume stands at 2.99 Million shares. Allergan Plc (NYSE:AGN) has a market capitalization of $44.9 Billion and most recently 339 Million outstanding shares have been calculated.

According to sentiments of 17 analysts the mean estimates of short term price target for the company’s stock is marked at $202.71. The most optimistic analyst sees the stock reaching $257 while the most conventional predicts the target price at $145.

In terms of Buy/Sell recommendations, 16 analysts have a consensus rating of 1.94 on the shares of Allergan Plc (NYSE:AGN). Out of rating recommendations 7 have given the stock a Buy while 5 recommend the stock as Outperform. 9 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Allergan Plc (NYSE:AGN)’s shares slipped -8.01% in the past week and plunged -9.04% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -28.69% while its year to date performance is at -0.91%.

While taking a glance at financials, we can look at a number of key indicators. Allergan Plc (NYSE:AGN) has a Return on Assets (ROA) of 2. The company currently has a Return on Equity (ROE) of 3.1 and a Return on Investment (ROI) of -2.1. Average true range (ATR-14) of the company sets at 4.6, along with its weekly and monthly volatility of 3.16% and 2.80% respectively. Relative strength index (RSI-14) for Allergan Plc (NYSE:AGN) is at 29.72. Beta value of the stock stands at 1.55.

The company’s price to free cash flow for trailing twelve months is 9.36. Its quick ratio for most recent quarter is 0.8 along with current ratio for most recent quarter of 0.9. Total debt to equity ratio of Allergan Plc (NYSE:AGN) for most recent quarter is 0.33 whereas long term debt to equity ratio for most recent quarter is 0.32.

Shares of Novartis Ag (NYSE:NVS) plunged -0.76% or -0.68 to reach at $88.32 during previous trading session. Novartis Ag (NYSE:NVS) has a market capitalization of $227.76 Billion and most recently 2.58 Billion outstanding shares have been calculated. A total of 1.43 Million shares exchanged hands, whereas the company’s average trading volume stands at 2.48 Million shares.

According to 2 analysts Novartis Ag (NYSE:NVS)’s price will reach at $100 during 52 weeks. Stock’s minimum price target estimates has been figured out at $94 while the maximum price target forecast is established at $106.

According to the recommendations from 9 analysts stock has mean rating of 1.89 on the shares of Novartis Ag (NYSE:NVS). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Novartis Ag (NYSE:NVS) climbed 0.91% in the past week and soared 1.85% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 5.66% while its year to date performance is at 2.93%.

Total debt to equity ratio of Novartis Ag (NYSE:NVS) for most recent quarter is 0.41 whereas long term debt to equity ratio for most recent quarter is 0.29. The company’s price to free cash flow for trailing twelve months is 41.46. Its quick ratio for most recent quarter is 1 along with current ratio for most recent quarter of 1.2.

Average true range (ATR-14) of the company sets at 1.11, along with its weekly and monthly volatility of 0.77% and 0.85% respectively. Relative strength index (RSI-14) for Novartis Ag (NYSE:NVS) is at 54.81. Beta value of the stock stands at 0.73. Novartis Ag (NYSE:NVS) has a Return on Assets (ROA) of 9.7. The company currently has a Return on Equity (ROE) of 17.9 and a Return on Investment (ROI) of 7.1.